HSP90AA1 and breast cancer: Thorough interpretation of this molecular mechanism will further explain the biological significance of plasma Hsp90α as a diagnostic biomarker, and initially verify the viability of eHsp90α as a therapeutic target for pathogenic lymphangiogenesis in breast cancer.